Murine infection models for aspergillus terreus pulmonary aspergillosis reveal long-term persistence of conidia and liver degeneration

Journal of Infectious Diseases

Volumn 205, Issue 8, 2012, Pages 1268-1277

  Slesiona, Silvia ^a   Ibrahim Granet, Oumaima ^b   Olias, Philipp ^c   Brock, Matthias ^d   Jacobsen, Ilse D ^a  

^a HANS KNÖLL INSTITUTE   (Germany)

^b INSTITUT PASTEUR   (France)

^c FREIE UNIVERSITÄT BERLIN   (Germany)

^d Leibniz Institute for Natural Product Research and Infection Biology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CORTISONE ACETATE; CYCLOPHOSPHAMIDE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 22; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPERGILLUS FUMIGATUS; ASPERGILLUS TERREUS; BIOLUMINESCENCE; CONIDIUM; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE SEQUENCE; HEN; LEUKOPENIA; LIVER FATTY DEGENERATION; LUNG ASPERGILLOSIS; MORTALITY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SPECIES DIFFERENTIATION;

ANIMALS; ASPERGILLUS; CHICK EMBRYO; CORTISONE; FEMALE; IMMUNOSUPPRESSIVE AGENTS; LEUKOPENIA; LIVER DISEASES; MICE; MICE, INBRED BALB C; PULMONARY ASPERGILLOSIS; SPORES, FUNGAL; VIRULENCE;

EID: 84859018378     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis193     Document Type: Article

References (37)

1. Patterson TF, Kirkpatrick WR, White M, et al. Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group. Medicine (Baltimore) 2000; 79:250-60.
2. Wald A, Leisenring W, van Burik JA, Bowden RA. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J Infect Dis 1997; 175:1459-66.
3. Lin SJ, Schranz J, Teutsch SM. Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 2001; 32:358-66.
4. Marr KA, Carter RA, Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002; 34:909-17.
5. Khoo SH, Denning DW. Invasive aspergillosis in patients with AIDS. Clin Infect Dis 1994; 19(Suppl 1):S41-8.
6. Lass-Flörl C, Griff K, Mayr A, et al. Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience. Br J Haematol 2005; 131:201-7.
7. Auberger J, Lass-Florl C, Ulmer H, et al. Significant alterations in the epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies. Int J Hematol 2008; 88: 508-15.
8. Perfect JR, Cox GM, Lee JY, et al. The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis. Clin Infect Dis 2001; 33:1824-33.
9. Denning DW, Marinus A, Cohen J, et al. An EORTC multicentre prospective survey of invasive aspergillosis in haematological patients: diagnosis and therapeutic outcome. EORTC Invasive Fungal Infections Cooperative Group. J Infect 1998; 37:173-80.
10. Balajee SA. Aspergillus terreus complex. Med Mycol 2009; 47(suppl 1): S42-6.
11. Dixon DM, Polak A, Walsh TJ. Fungus dose-dependent primary pulmonary aspergillosis in immunosuppressed mice. Infect Immun 1989; 57:1452-6.
12. Nawada R, Amitani R, Tanaka E, et al. Murine model of invasive pulmonary aspergillosis following an earlier stage, noninvasive Aspergillus infection. J Clin Microbiol 1996; 34:1433-9.
13. Sarfati J, Diaquin M, Debeaupuis JP, et al. A new experimental murine aspergillosis model to identify strains of Aspergillus fumigatus with reduced virulence. Nippon Ishinkin Gakkai Zasshi 2002; 43:203-13.
14. Sheppard DC, Rieg G, Chiang LY, Filler SG, Edwards JE Jr, Ibrahim AS. Novel inhalational murine model of invasive pulmonary aspergillosis. Antimicrob Agents Chemother 2004; 48:1908-11.
15. Steinbach WJ, Benjamin DK Jr, Trasi SA, et al. Value of an inhalational model of invasive aspergillosis. Med Mycol 2004; 42:417-25.
16. Stephens-Romero SD, Mednick AJ, Feldmesser M. The pathogenesis of fatal outcome in murine pulmonary aspergillosis depends on the neutrophil depletion strategy. Infect Immun 2005; 73:114-25.
17. Walsh TJ, Petraitis V, Petraitiene R, et al. Experimental pulmonary aspergillosis due to Aspergillus terreus: pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B. J Infect Dis 2003; 188:305-19.
18. Gressler M, Zaehle C, Scherlach K, Hertweck C, Brock M. Multifactorial induction of an orphan PKS-NRPS gene cluster in Aspergillus terreus. Chem Biol 2011; 18:198-209.
19. Härtl A, Hillesheim HG, Kunkel W, Schrinner EJ. The Candida infected hen's egg. An alternative test system for systemic anticandida activity. Arzneimittelforschung 1995; 45:926-8.
20. Jacobsen ID, Grosse K, Slesiona S, Hube B, Berndt A, Brock M. Embryonated eggs as an alternative infection model to investigate Aspergillus fumigatus virulence. Infect Immun 2010; 78:2995-3006.
21. Brock M, Jouvion G, Droin-Bergere S, Dussurget O, Nicola MA, Ibrahim-Granet O. Bioluminescent Aspergillus fumigatus, a new tool for drug efficiency testing and in vivo monitoring of invasive aspergillosis. Appl Environ Microbiol 2008; 74:7023-35.
22. Ibrahim-Granet O, Jouvion G, Hohl TM, et al. In vivo bioluminescence imaging and histopathologic analysis reveal distinct roles for resident and recruited immune effector cells in defense against invasive aspergillosis. BMC Microbiol 2010; 10:105.
23. Howard DH. Intracellular behavior of histoplasma capsulatum. J Bacteriol 1964; 87:33-8.
24. Olias P, Gruber AD, Hafez HM, et al. Molecular epidemiology and virulence assessment of Aspergillus fumigatus isolates from white stork chicks and their environment. Vet Microbiol 2011; 148: 348-55.
25. Liebmann B, Muller M, Braun A, Brakhage AA. The cyclic AMPdependent protein kinase a network regulates development and virulence in Aspergillus fumigatus. Infect Immun 2004; 72:5193-203.
26. Schöbel F, Jacobsen ID, Brock M. Evaluation of lysine biosynthesis as an antifungal drug target: biochemical characterization of Aspergillus fumigatus homocitrate synthase and virulence studies. Eukaryot Cell 2010; 9:878-93.
27. Johnson EM, Oakley KL, Radford SA, et al. Lack of correlation of in vitro amphotericin B susceptibility testing with outcome in a murine model of Aspergillus infection. J Antimicrob Chemother 2000; 45:85-93.
28. Nobre G. Sensitivity to 5-fluorocytosine and virulence for mice of some human isolates of Aspergillus. Mycopathologia 1977; 62:57-60.
29. Warn PA, Morrissey G, Morrissey J, Denning DW. Activity of micafungin (FK463) against an itraconazole-resistant strain of Aspergillus fumigatus and a strain of Aspergillus terreus demonstrating in vivo resistance to amphotericin B. J Antimicrob Chemother 2003; 51: 913-19.
30. Balloy V, Huerre M, LatgéJP, Chignard M. Differences in patterns of infection and inflammation for corticosteroid treatment and chemotherapy in experimental invasive pulmonary aspergillosis. Infect Immun 2005; 73:494-503.
31. Clemons KV, Grunig G, Sobel RA, Mirels LF, Rennick DM, Stevens DA. Role of IL-10 in invasive aspergillosis: increased resistance of IL-10 gene knockout mice to lethal systemic aspergillosis. Clin Exp Immunol 2000; 122:186-91.
32. Armstrong-James DP, Turnbull SA, Teo I, et al. Impaired interferongamma responses, increased interleukin-17 expression, and a tumor necrosis factor-alpha transcriptional program in invasive aspergillosis. J Infect Dis 2009; 200:1341-51.
33. Werner JL, Metz AE, Horn D, et al. Requisite role for the dectin-1 beta-glucan receptor in pulmonary defense against Aspergillus fumigatus. J Immunol 2009; 182:4938-46.
34. Zelante T, Bozza S, De Luca A, et al. Th17 cells in the setting of Aspergillus infection and pathology. Med Mycol 2009; 47(suppl 1): S162-9.
35. Zelante T, De Luca A, Bonifazi P, et al. IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur J Immunol 2007; 37:2695-706.
36. Duong M, Ouellet N, Simard M, Bergeron Y, Olivier M, Bergeron MG. Kinetic study of host defense and inflammatory response to Aspergillus fumigatus in steroid-induced immunosuppressed mice. J Infect Dis 1998; 178:1472-82.
37. Schelenz S, Smith DA, Bancroft GJ. Cytokine and chemokine responses following pulmonary challenge with Aspergillus fumigatus: obligatory role of TNF-alpha and GM-CSF in neutrophil recruitment. Med Mycol 1999; 37:183-94.